Pharmacokinetics of methohexital during cardiovascular surgery with cardiopulmonary bypass.
The pharmacokinetics of methohexital after intravenous bolus administration was studied during cardiovascular surgery with cardiopulmonary bypass. The effect of body temperature (normothermia and hypothermia) during cardiopulmonary bypass on methohexital pharmacokinetics was investigated. The pharmacokinetic data obtained were compared with those from vascular surgery without cardiopulmonary bypass. A marked decrease in plasma methohexital concentrations and therefore in area under curve and a significant increase in clearance and in volume of distribution were observed in the cardiopulmonary bypass groups compared to the vascular surgery group without cardiopulmonary bypass. However, the elimination half-life and the mean residence time were similar in the 2 groups. Furthermore, the study shows that body temperature during cardiopulmonary bypass does not influence methohexital pharmacokinetics.
Foussadier
A
A
Hôpital Cardiovasculaire et Pneumologique, Service Pharmaceutique, BP Lyon-Montchat, France.
Boulieu
R
R
Lehot
J J
JJ
Ferry
S
S
D000328:Adult; D000368:Aged; D001831:Body Temperature / Q000502:physiology; D002315:Cardiopulmonary Bypass; D013504:Cardiovascular Surgical Procedures; D005260:Female; D006207:Half-Life; D006801:Humans; D007275:Injections, Intravenous; D007432:Intraoperative Period; D008297:Male; D008723:Methohexital / Q000008:administration & dosage / Q000493:pharmacokinetics*; D008875:Middle Aged
D008723:Methohexital